204 related articles for article (PubMed ID: 37031468)
1. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.
Konstantis G; Efstathiou S; Pourzitaki C; Kitsikidou E; Germanidis G; Chourdakis M
Clin Nutr; 2023 May; 42(5):800-809. PubMed ID: 37031468
[TBL] [Abstract][Full Text] [Related]
2. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis.
Zhang Y; Li L; Guo C; Mu D; Feng B; Zuo X; Li Y
BMC Gastroenterol; 2016 Jun; 16(1):62. PubMed ID: 27296254
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
Didari T; Mozaffari S; Nikfar S; Abdollahi M
World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
[TBL] [Abstract][Full Text] [Related]
4. Probiotics for management of functional abdominal pain disorders in children.
Wallace C; Gordon M; Sinopoulou V; Akobeng AK
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD012849. PubMed ID: 36799531
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J
Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427
[TBL] [Abstract][Full Text] [Related]
6. Dietary interventions for recurrent abdominal pain in childhood.
Newlove-Delgado TV; Martin AE; Abbott RA; Bethel A; Thompson-Coon J; Whear R; Logan S
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010972. PubMed ID: 28334433
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
Zhang T; Zhang C; Zhang J; Sun F; Duan L
Front Cell Infect Microbiol; 2022; 12():859967. PubMed ID: 35433498
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis.
Sun JR; Kong CF; Qu XK; Deng C; Lou YN; Jia LQ
Saudi J Gastroenterol; 2020; 26(2):66-77. PubMed ID: 31898645
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis.
Yang R; Jiang J; Ouyang J; Zhao Y; Xi B
Clin Nutr ESPEN; 2024 Apr; 60():362-372. PubMed ID: 38479936
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
Goodoory VC; Khasawneh M; Black CJ; Quigley EMM; Moayyedi P; Ford AC
Gastroenterology; 2023 Nov; 165(5):1206-1218. PubMed ID: 37541528
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials.
Niu HL; Xiao JY
Int J Surg; 2020 Mar; 75():116-127. PubMed ID: 32014597
[TBL] [Abstract][Full Text] [Related]
13. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live
Srivastava S; Basak U; Naghibi M; Vijayakumar V; Parihar R; Patel J; Jadon PS; Pandit A; Dargad RR; Khanna S; Kumar S; Day R
Gut Microbes; 2024; 16(1):2338322. PubMed ID: 38630015
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and safety of probiotics for the treatment of irritable bowel syndrome: a systematic review and network meta-analysis protocol.
Yang M; Yu Y; Lei PG; Yuan J
BMJ Open; 2019 Dec; 9(12):e027376. PubMed ID: 31796470
[TBL] [Abstract][Full Text] [Related]
15. Homeopathy for treatment of irritable bowel syndrome.
Peckham EJ; Cooper K; Roberts ER; Agrawal A; Brabyn S; Tew G
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD009710. PubMed ID: 31483486
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.
Shang X; E FF; Guo KL; Li YF; Zhao HL; Wang Y; Chen N; Nian T; Yang CQ; Yang KH; Li XX
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745212
[TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
[TBL] [Abstract][Full Text] [Related]
18. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
Xie P; Luo M; Deng X; Fan J; Xiong L
Nutrients; 2023 Sep; 15(17):. PubMed ID: 37686889
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.
Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
Am J Gastroenterol; 2014 Oct; 109(10):1547-61; quiz 1546, 1562. PubMed ID: 25070051
[TBL] [Abstract][Full Text] [Related]
20. Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs.
Wang Y; Chen N; Niu F; Li Y; Guo K; Shang X; E F; Yang C; Yang K; Li X
Int J Colorectal Dis; 2022 Nov; 37(11):2263-2276. PubMed ID: 36251040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
